• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New oral anticoagulants versus Warfarin in patients undergoing cardioversion of atrial fibrillation.

作者信息

Andò Giuseppe, Trio Olimpia

机构信息

Department of Clinical and Experimental Medicine, University of Messina, Italy.

Department of Clinical and Experimental Medicine, University of Messina, Italy.

出版信息

Int J Cardiol. 2016 Dec 15;225:244-246. doi: 10.1016/j.ijcard.2016.09.126. Epub 2016 Oct 1.

DOI:10.1016/j.ijcard.2016.09.126
PMID:27736714
Abstract
摘要

相似文献

1
New oral anticoagulants versus Warfarin in patients undergoing cardioversion of atrial fibrillation.新型口服抗凝剂与华法林用于房颤复律患者的比较
Int J Cardiol. 2016 Dec 15;225:244-246. doi: 10.1016/j.ijcard.2016.09.126. Epub 2016 Oct 1.
2
Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis.非维生素 K 拮抗剂口服抗凝药与华法林在心房颤动转复中同样安全有效：系统评价和荟萃分析。
Int J Cardiol. 2018 Oct 1;268:143-148. doi: 10.1016/j.ijcard.2018.04.034.
3
Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).在心房颤动转复后应用阿哌沙班的疗效和安全性：来自 ARISTOTLE 试验（阿哌沙班用于减少心房颤动中的中风和其他血栓栓塞事件）的见解。
J Am Coll Cardiol. 2014 Mar 25;63(11):1082-7. doi: 10.1016/j.jacc.2013.09.062. Epub 2013 Nov 6.
4
[Termination of paroxysm of atrial fibrillation conversion using oral propafenone after unsuccessful electrical cardioversion].[电复律失败后口服普罗帕酮终止心房颤动发作的转复情况]
Kardiologiia. 2012;52(4):95-6.
5
[Anticoagulation in atrial fibrillation before cardioversion].[房颤复律前的抗凝治疗]
Dtsch Med Wochenschr. 1999 Apr 1;124(13):407.
6
Real-life experience with non-vitamin K antagonist oral anticoagulants versus warfarin in patients undergoing elective cardioversion of atrial fibrillation.非维生素 K 拮抗剂口服抗凝剂与华法林在择期行心房颤动转复患者中的真实世界经验。
Ann Noninvasive Electrocardiol. 2020 Sep;25(5):e12766. doi: 10.1111/anec.12766. Epub 2020 Apr 29.
7
Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial.计划进行电复律的非瓣膜性心房颤动患者的自发转复：心房颤动电复律患者中依度沙班与华法林对比研究（ENSURE-AF）试验的亚组分析
Am Heart J. 2019 Mar;209:131-135. doi: 10.1016/j.ahj.2018.10.008. Epub 2018 Nov 22.
8
[Cardioversion in atrial fibrillation].
Rev Prat. 2002 Jun 15;52(12):1313-6.
9
Evaluating cardioversion outcomes for atrial fibrillation on novel oral anticoagulants versus warfarin: experience at a tertiary referral centre.评估新型口服抗凝药与华法林用于心房颤动复律的效果：一家三级转诊中心的经验
Ir J Med Sci. 2017 Aug;186(3):615-620. doi: 10.1007/s11845-017-1582-3. Epub 2017 Feb 24.
10
Rivaroxaban vs. Warfarin for Anticoagulation in Patients with Atrial Fibrillation Undergoing Ablation and Cardioversion.利伐沙班与华法林用于接受消融和心脏复律的房颤患者抗凝治疗的比较
Am Fam Physician. 2016 Oct 1;94(7):Online.

引用本文的文献

1
How to Optimize Cardioversion of Atrial Fibrillation.如何优化心房颤动的心脏复律
J Clin Med. 2022 Jun 12;11(12):3372. doi: 10.3390/jcm11123372.
2
Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion.心房颤动患者电复律时直接口服抗凝剂的管理。
Medicina (Kaunas). 2019 Sep 30;55(10):660. doi: 10.3390/medicina55100660.